NTMT1
N-terminal Xaa-Pro-Lys N-methyltransferase 1
Also known as: AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1, NTM1A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BV86
- Gene
- NTMT1
- Ensembl
- ENSG00000148335
- Chromosome
- 9
- Canonical length
- 223 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The METTL11A gene encodes an N-terminal methyltransferase for the RAN (MIM 601179) guanine nucleotide exchange factor regulator of chromosome condensation 1 (RCC1; MIM 179710). METTL11A enzyme alpha-N-methylates other protein targets such as SET (MIM 600960) and RB (MIM 180200).[supplied by OMIM, Nov 2010]
Canonical amino-acid sequenceUniProt
223 residues, UniProt reviewed canonical sequence.
>Q9BV86|NTMT1
1 MTSEVIEDEK QFYSKAKTYW KQIPPTVDGM LGGYGHISSI DINSSRKFLQ RFLREGPNKT
61 GTSCALDCGA GIGRITKRLL LPLFREVDMV DITEDFLVQA KTYLGEEGKR VRNYFCCGLQ
121 DFTPEPDSYD VIWIQWVIGH LTDQHLAEFL RRCKGSLRPN GIIVIKDNMA QEGVILDDVD
181 SSVCRDLDVV RRIICSAGLS LLAEERQENL PDEIYHVYSF ALRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NTMT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 95 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 95 nTPM
- testis: 90 nTPM
- tongue: 79 nTPM
- adrenal gland: 66 nTPM
- heart muscle: 65 nTPM
- choroid plexus: 47 nTPM
Single-cell type
- late spermatids: 1,077 nCPM
- early spermatids: 417 nCPM
- late primary spermatocytes: 362 nCPM
- syncytiotrophoblasts: 159 nCPM
- migrating cytotrophoblasts: 109 nCPM
- epididymal efferent duct absorptive cells: 94 nCPM
Immune cell
- non-classical monocyte: 71 nTPM
- intermediate monocyte: 55 nTPM
- plasmacytoid DC: 53 nTPM
- naive B-cell: 51 nTPM
- classical monocyte: 50 nTPM
- myeloid DC: 49 nTPM
Brain region
- midbrain: 28 nTPM
- cerebellum: 27 nTPM
- white matter: 27 nTPM
- hypothalamus: 26 nTPM
- thalamus: 26 nTPM
- medulla oblongata: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 1.29
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromosome segregation
- spindle organization
- N-terminal peptidyl-glycine methylation
- N-terminal peptidyl-proline dimethylation
- N-terminal peptidyl-serine dimethylation
- N-terminal peptidyl-serine trimethylation
Molecular functions
- histone methyltransferase activity
- N-terminal protein N-methyltransferase activity
- protein methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NTMT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NTMT1 as an antibody target. Whether an autoantibody or antibody against NTMT1 could matter depends on whether native NTMT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NTMT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NTMT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...